Evidence map›Paper›PMID 33792981›Full record

ReviewCytopathology : official journal of the British Society for Clinical Cytology2021

Next generation sequencing in cytology.

Pasquale Pisapia, Francesco Pepe, Roberta Sgariglia, Mariantonia Nacchio, Gianluca Russo, Floriana Conticelli, Ilaria Girolami, Albino Eccher, Claudio Bellevicine, Elena Vigliar and 2 more

Abstract readReview
In one paragraph

Review in Cytopathology : official journal of the British Society for Clinical Cytology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Liquid biopsy in lung cancer.Breathe (Sheffield, England) · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Next step of molecular pathology: next-generation sequencing in cytology.Journal of pathology and translational medicine · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Pathologica · 2023
    Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Next generation sequencing in cytology.Cytopathology : official journal of the British Society for Clinical Cytology · 2021
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Pasquale PisapiaDepartment of Public Health, University of Naples Federico II, Naples, Italy.ORCID https://orcid.org/0000-0002-6429-0620
Francesco PepeDepartment of Public Health, University of Naples Federico II, Naples, Italy.
Roberta SgarigliaDepartment of Public Health, University of Naples Federico II, Naples, Italy.
Mariantonia NacchioDepartment of Public Health, University of Naples Federico II, Naples, Italy.
Gianluca RussoDepartment of Public Health, University of Naples Federico II, Naples, Italy.
Floriana ConticelliDepartment of Public Health, University of Naples Federico II, Naples, Italy.
Ilaria GirolamiDivision of Pathology, Central Hospital Bolzano, Bolzano, Italy.ORCID https://orcid.org/0000-0003-3537-4929
Albino EccherDepartment of Pathology and Diagnostics, University and Hospital Trust of Verona, Verona, Italy.ORCID https://orcid.org/0000-0002-9992-5550
Claudio BellevicineDepartment of Public Health, University of Naples Federico II, Naples, Italy.
Elena VigliarDepartment of Public Health, University of Naples Federico II, Naples, Italy.
Umberto MalapelleDepartment of Public Health, University of Naples Federico II, Naples, Italy.
Giancarlo TronconeDepartment of Public Health, University of Naples Federico II, Naples, Italy.ORCID https://orcid.org/0000-0003-1630-5805

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The application of next generation sequencing (NGS) technology to cytological samples has significantly modified molecular cytopathology practice. Cytological samples represent a valid source of high-quality DNA for NGS analysis, especially for predicting patients' response to targeted treatments and for refining the risk of malignancy in indeterminate cytological diagnoses. However, several pre-analytical factors may influence the reliability of NGS clinical analysis. Here, we briefly review the challenges of NGS in cytology practice, focusing on those pre-analytical factors that may negatively affect NGS success rates and routine diagnostic applications. Finally, we address the future directions of the field.

Indexed as

CytodiagnosisCytological TechniquesHigh-Throughput Nucleotide SequencingHumansNeoplasmsbiomarkerscytopathologyFNAmolecular cytopathologynext generation sequencing

Identifiers

PMID33792981
PMCPMC8451925

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.